Evidence check: CYP2D6 in the context of weight loss

CYP2D6 is a key drug-metabolizing enzyme, not directly linked to weight loss. Some research explores whether CYP2D6 variants affect the metabolism of drugs that may influence body weight (e.g., certain antidepressants, beta-blockers), but effect sizes are small and inconsistent. No robust evidence supports using CYP2D6 genotype to guide diet or exercise for weight loss. The evidence is mechanistic/pharmacogenetic, not from controlled weight-loss trials. Direct-to-consumer tests that claim CYP2D6 affects weight are marketing hype. If you take medications metabolized by CYP2D6, genotyping may help with dosing, but that is unrelated to weight management. For weight loss, focus on established factors: calorie balance, physical activity, and behavioral change. Evidence: unclear/mixed. Safety note: CYP2D6 poor metabolizers may have altered drug responses; consult a doctor before changing any medication.